Polymorphic forms of imatinib mesylate, process for new preparation of new crystalline, amorphous and alpha form, related pharmaceutical compositions, their preparation and use processes

摘要

Solvates and crystalline forms of imatinib mesylate are described. Further, methods for preparing such solvates and crystalline forms of imatinib mesylate are described.